Atlas Trials

Clinical Efficacy of Tumour Treatment Vaccine (TTV) Combined With PD-1 in the Treatment of Relapsed Refractory Advanced Solid Tumours

Clinical trial NCT06430502 · RECRUITING

Trial details

NCT number
NCT06430502
Sponsor
Wuxi People's Hospital
Status
RECRUITING
Phase
Not Applicable
Study type
INTERVENTIONAL
CancerPD-L1 Gene Mutation
Start date
2024-05-07
Primary completion
2027-06-01
Enrollment
200

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.